Small Molecules

24 Apr 2007 Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
24 Apr 2007 AstraZeneca announces decision to discontinue collaboration with AtheroGenics regarding AGI-1067
24 Apr 2007 Synosia Therapeutics Announces Second Major Pharmaceutical Deal
24 Apr 2007 Ceragenix Announces New Publication of Scientific Research on Ceragenin(TM) Technology
24 Apr 2007 Bionomics completes GMP synthesis of cancer drug BNC105 on time and on budget
24 Apr 2007 Vectura Announces Successful Outcome of Second Phase IIb Clinical Study on Inhaled Erectile Dysfunction Product
21 Apr 2007 FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
21 Apr 2007 Addex reports positive results in Phase IIa clinical trial with ADX10059 in Migraine
21 Apr 2007 UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
21 Apr 2007 Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential to Accelerate Recovery of Bone Marrow Stem Cells Following Cancer Radiation Therapy
20 Apr 2007 Novartis expands late-stage oncology pipeline with AS1404, a novel agent shown to break down blood vessels that support tumor growth
20 Apr 2007 Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV
20 Apr 2007 CuraGen and TopoTarget Present New Clinical Results with Belinostat at the Annual Meeting in ASCO and at the conference "2007 Pan Pacific Lymphoma"
20 Apr 2007 Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
20 Apr 2007 Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
20 Apr 2007 Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
20 Apr 2007 VioQuest Pharmaceuticals announces data presentation for its Akt inhibitor VQD-002, at American Association for Cancer Research annual meeting
20 Apr 2007 Abbott Submits New Drug Application for Combination Niaspan(R)/Simvastatin Tablet
19 Apr 2007 Completion of Phase I Trial on the Anti-influenza Drug CS-8958
19 Apr 2007 EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
19 Apr 2007 European Regulatory Authorities Accept MediGene's Marketing Authorization Application for Polyphenon E(R) Ointment for Review
19 Apr 2007 A Once-weekly Formulation of Risedronate Sodium Hydrate, an Antiosteoporotic Agent, Was Approved in Japan
19 Apr 2007 Thallion Presents Data at the 2007 Annual Meeting of the American Association of Cancer Research on its Oncology Drug Candidates ECO-4601 and CAP-232
19 Apr 2007 Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
19 Apr 2007 Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top